MERAH PUTIH Vaccine Will Be Used as Primary Vaccine
said that the Merah Putih vaccine which was developed in collaboration with Airlangga University is targeted to be used starting in August 2022. The red and white vaccine is planned to be used as the first and second primary doses of vaccines, as well as booster vaccines or third doses of vaccines. "Please pray for your blessing so that the clinical trial runs smoothly and according to the target. In August, the Indonesian people can use the Red and White vaccine, both as a primary and booster vaccine," Sudirman said at a press conference. The use of the Red and White vaccine is carried out after the vaccine has gone through phase 1, 2, and 3 clinical trials, and has obtained an emergency use authorization (EUA) from the Food and Drug Administration (BPOM) which is targeted for July 2022. BPOM has just given the Clinical Trial Protocol Approval (PPUK) for the Red and White vaccines for phases 1 and 2. Previously, PT Biotis Pharmaceutical had obtained Good Manufacturing Practices (CPOB) certification for fill and finish facilities.
|•SOURCE•| Articles :KOMPAS | Image :BISNIS |
READ MORE
|• NATIONAL •|Aggressive Tariff For Super Rich
|• INTERNATIONAL •|Winner Of 2021 Indonesia Corporate
|• BANKING •|SINARMAS Land Encourages Stratup To
|• POLITICS •|Employee Working Hours Will Be Arranged
|• SCIENCE •|Initial Screening Of Convalescent Donors
0 comments: